Neuroscience David E. Wright, Ph.D. Director, Office of Research - - PowerPoint PPT Presentation

neuroscience
SMART_READER_LITE
LIVE PREVIEW

Neuroscience David E. Wright, Ph.D. Director, Office of Research - - PowerPoint PPT Presentation

Research Integrity in Neuroscience David E. Wright, Ph.D. Director, Office of Research Integrity OASH/DHHS David.Wright@hhs.gov ORIs Mission Mission: To promote the integrity of PHS-supported extramural and intramural research programs by


slide-1
SLIDE 1

Research Integrity in Neuroscience

David E. Wright, Ph.D. Director, Office of Research Integrity OASH/DHHS David.Wright@hhs.gov

slide-2
SLIDE 2
slide-3
SLIDE 3

ORI’s Mission

Mission: To promote the integrity of PHS-supported extramural and intramural research programs by administering the PHS Research Misconduct Regulation, 42 CFR Part 93 and  Responding effectively to allegations of research misconduct  Promoting research integrity

slide-4
SLIDE 4

Definition of Research Misconduct

 Fabrication is making up data or results and recording or reporting them  Falsification is manipulating research materials, equipment, or processes, or changing or omitting data or results such that the research is not accurately represented in the research record

slide-5
SLIDE 5

Definition of Research Misconduct

 Plagiarism is the appropriation of another person’s ideas, processes, results, or words without giving appropriate credit  Research misconduct does not include honest error or differences of opinion (42 CFR Part 93.103)

slide-6
SLIDE 6

Some ORI Statistics

1992 to 2010* statistics:  Total misconduct findings 224  Findings involving clinical research ~30%  Total accessions from 1992 4377  Total cases opened from 1992 580  Total cases closed from 1992 630  Total Allegations per year before 2007 =225  Total Allegations per year in 2012-3=425

slide-7
SLIDE 7

Percent of Cases Involving Images

0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 89-'90 91-'92 93-'94 95-'96 97-'98 99-'00 01-'02 03-'04 05-'06 07-'08 2-Year Reporting Period Percent of Cases

slide-8
SLIDE 8

Research Integrity Issues in Emerging Fields Such As Neuroscience

 Research misconduct issues are mostly the same across disciplines and fields of research regardless of their maturity . . . With some nuances

slide-9
SLIDE 9

Research Integrity Issues in Emerging Fields Such As Neuroscience

 In newly emerging fields there may be techniques that grant and journal reviewers are not yet familiar with that could make detecting F or F harder.

slide-10
SLIDE 10

Research Integrity Issues in Emerging Fields Such As Neuroscience

 On the other hand, in “hot” new fields more and more people are watching developments closely making it more likely that misconduct might be discovered.

slide-11
SLIDE 11

Research Integrity Issues in Emerging Fields Such As Neuroscience

 Hot new fields attract lots of new people in pursuit of funds and fame and create intense competition. That combination may make misconduct more likely.  As money pours into emerging fields where new discoveries can have near-term applications in medicine

  • r industry, conflict of interest issues may become more

prominent.

slide-12
SLIDE 12

Research Integrity Issues in Emerging Fields Such As Neuroscience

 In clinical neuroscience publications have evolved from case reports to results of hypothesis driven research. F & F may increase according.

slide-13
SLIDE 13

Preventing Research Misconduct

 Training in the Responsible Conduct or Research (RCR)  Rigorous data management policies enforced by PI’s who review all grant proposals and manuscripts along side the raw data supporting those proposals and manuscripts before they leave the lab.